Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese cohort data from NCT03121846
ConclusionWith the largest Chinese STS cohort to date, we report that apatinib show good efficacy in advanced STS subjects with significant higher ORR and some adverse events may predict prognosis.Graphical abstract
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
More News: Chemotherapy | China Health | Drugs & Pharmacology | Hypertension | Pain | Proteinuria | Sarcomas | Skin | Soft Tissue Sarcoma | Study